MedPath

The influence of stress and lifestyle in hereditary angioedema

Not Applicable
Completed
Conditions
Hereditary angioedema
Human Genetics and Inherited Disorders - Other human genetics and inherited disorders
Skin - Other skin conditions
Inflammatory and Immune System - Other inflammatory or immune system disorders
Registration Number
ACTRN12621000473864
Lead Sponsor
niversity of Auckland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
3
Inclusion Criteria

Inclusion criteria – people who:
1.Have been diagnosed by a Clinical Immunologist, to be suffering from hereditary angioedema which does not respond to antihistamine or corticosteroid treatment (determined by family history, presence of symptoms of angioedema, low C1 inhibitor level or function or genetic studies)
2.Have access to on-demand medication
3.Are aged 18 and above
4.Are currently and for the duration of the study, residing in New Zealand
5.Have access to a computer and internet connection to access the online intervention

Exclusion Criteria

Exclusion criteria – people who:
1.Are unable to comprehend the information sheet and the consent form or unable to give consent.
2.Are participating in another clinical trial
3.Are engaged in another lifestyle intervention, such as working with a health professional on making lifestyle changes
4.Have acquired angioedema
5.Do not have access to on-demand medication
6.Are aged 17 or less
7.Reside outside of New Zealand or planning to during the study
8.Do not have access to a computer and / or do not have access to an internet connection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ifestyle quality score (comprising Firstbeat Lifestyle Assessment overall lifestyle assessment score, stress and recovery balance score, restorative effect of sleep score and health effects of physical activity score)[Week 1, Week 13 and follow-up at week 25];Quality of life measured by the HAE Quality of Life Questionnaire (AE-QoL)[Week 1, Week 13 and follow-up at week 25];Swelling attack activity measured by the Angioedema Activity Score Questionnaire (AAS)[Week 1, Week 13 and follow-up at week 25]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath